BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19428118)

  • 1. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
    Tadić A; Helmreich I; Mergl R; Hautzinger M; Kohnen R; Henkel V; Hegerl U
    J Affect Disord; 2010 Jan; 120(1-3):86-93. PubMed ID: 19428118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
    J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.
    Helmreich I; Wagner S; König J; Kohnen R; Szegedi A; Hiemke C; Tadić A
    J Affect Disord; 2015 Apr; 175():199-208. PubMed ID: 25638793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.
    Lin CH; Chen CC; Wang FC; Lane HY
    Psychiatry Clin Neurosci; 2013 May; 67(4):265-72. PubMed ID: 23683158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidal thinking and behavior during treatment with sertraline in late-life depression.
    Nelson JC; Delucchi K; Schneider L
    Am J Geriatr Psychiatry; 2007 Jul; 15(7):573-80. PubMed ID: 17586782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.
    Helmreich I; Wagner S; Mergl R; Allgaier AK; Hautzinger M; Henkel V; Hegerl U; Tadić A
    Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262(4):291-304. PubMed ID: 21959915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol of the Diabetes and Depression Study (DAD): a multi-center randomized controlled trial to compare the efficacy of a diabetes-specific cognitive behavioral group therapy versus sertraline in patients with major depression and poorly controlled diabetes mellitus.
    Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Müller MJ
    BMC Psychiatry; 2013 Aug; 13():206. PubMed ID: 23915015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
    Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year follow-up of a randomized controlled trial of sertraline and cognitive behavior group therapy in depressed primary care patients (MIND study).
    Mergl R; Allgaier AK; Hautzinger M; Coyne JC; Hegerl U; Henkel V
    J Affect Disord; 2018 Apr; 230():15-21. PubMed ID: 29355727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.
    Amidfar M; Khiabany M; Kohi A; Salardini E; Arbabi M; Roohi Azizi M; Zarrindast MR; Mohammadinejad P; Zeinoddini A; Akhondzadeh S
    J Clin Pharm Ther; 2017 Feb; 42(1):44-50. PubMed ID: 27809351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open study of sertraline in patients with major depression who failed to respond to moclobemide.
    George T; Theodoros MT; Chiu E; Krapivensky N; Hokin A; Tiller JW
    Aust N Z J Psychiatry; 1999 Dec; 33(6):889-95. PubMed ID: 10619217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
    Manber R; Buysse DJ; Edinger J; Krystal A; Luther JF; Wisniewski SR; Trockel M; Kraemer HC; Thase ME
    J Clin Psychiatry; 2016 Oct; 77(10):e1316-e1323. PubMed ID: 27788313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter open-label sertraline study in adolescent outpatients with major depression.
    Ambrosini PJ; Wagner KD; Biederman J; Glick I; Tan C; Elia J; Hebeler JR; Rabinovich H; Lock J; Geller D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):566-72. PubMed ID: 10230188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.
    Fann JR; Bombardier CH; Temkin N; Esselman P; Warms C; Barber J; Dikmen S
    J Head Trauma Rehabil; 2017; 32(5):332-342. PubMed ID: 28520672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder.
    Caliyurt O; Guducu F
    J Affect Disord; 2005 Sep; 88(1):75-8. PubMed ID: 15967511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.